...
...

glenmark pharmaceuticals news

Expert shares delicious way to boost your health with Candyceuticals

Get the nutrients you need in the candies you love
Published on Jul 09, 2026 01:35 pm IST

How Trump's 100% tariff on pharma imports could impact India. Explained

Donald Trump has announced that he will put import taxes of 100 per cent on pharmaceutical drugs.
Updated on Sept 27, 2025 12:00 am IST

Trump announces 100% tariff on drugs from Oct 1, Indian pharma exports at risk

President Donald Trump holds a signed presidential memorandum in the Oval Office at the White House.
Updated on Sept 27, 2025 12:04 am IST

Borderlands 4: Release date, time, where to play, editions and more

Borderlands 4 release date, time and more
Published on Sept 08, 2025 09:20 pm IST

Auto drivers assault EVP of pharma company in Kandivali East

Auto drivers assault EVP of pharma company in Kandivali East
Updated on Jun 14, 2024 09:10 am IST

Glenmark Pharma Q4 net profit falls 26 per cent to 173 crore

Representative image
Published on May 28, 2022 05:16 pm IST

Glenmark launches 1st nasal spray for treating adult Covid-19 patients in India

FabiSpray is designed to kill the Covid-19 virus in the upper airways.
Published on Feb 09, 2022 03:00 pm IST

Glenmark Life Sciences shares make muted debut, list at 4% premium

Glenmark Life Sciences shares listing comes days after its initial public offering (IPO) was oversubscribed 44 times.
Published on Aug 06, 2021 10:59 am IST

Glenmark, SaNOtize sign deal for Covid nasal spray in India, Asian countries

Glenmark chairperson and managing director Glenn Saldanha said the partnership with SaNOtize reflects Glenmark's focused approach against Covid-19.
Published on Aug 02, 2021 12:01 pm IST

Glenmark Life Sciences IPO fully subscribed on Day 1

Glenmark Life Sciences shares were available at a premium of 110 in the grey market, according to market observers.
Published on Jul 27, 2021 12:13 pm IST

Glenmark introduces cheaper drug for lung fibrosis in India

Nintedanib is approved by the Central Drugs Standard Control Organisation (CDSCO) for the treatment of Idiopathic (unknown cause) PF (IPF).
Published on Oct 14, 2020 12:54 pm IST

Glenmark’s Favipiravir drug shows encouraging results in Phase 3 clinical trial

About 69.8 per cent of patients in the Favipiravir treatment arm achieved clinical cure by Day 4, which was statistically significant compared to 44.9 per cent observed in the control arm.
Published on Jul 23, 2020 10:07 am IST

Glenmark Pharma cuts price of Covid-19 drug by 27 percent to 75 per tablet

Glenmark Pharmaceuticals cut antiviral drug Favipiravir’s price on Monday
Updated on Jul 13, 2020 01:08 pm IST

Glenmark Pharmaceuticals shares soar 20% after Covid-19 drug launch

Glenmark Pharmaceuticals has launched antiviral drug Favipiravir for treatment of Covid-19 patients.
Updated on Jun 22, 2020 12:46 pm IST

Glenmark launches Covid-19 drug at Rs 103 per tablet

The drug will be available as a prescription-based medication for Rs 103/tablet, with recommended dose being 1,800 mg twice on day one, followed by 800 mg twice daily up to day 14.
Updated on Jun 20, 2020 09:33 pm IST

Glenmark gets DGCI nod for clinical trial

The DCGI approved to conduct trials on Favipiravir antiviral tablets on Covid-19 patients, making Glenmark the first pharmaceutical firm in India to be given an approval to start the trial.
Published on May 01, 2020 03:49 am IST